Business
Citi slaps buy rating on ResMed shares
Image source: Getty Images
ResMed Inc (ASX: RMD) shares are in the red so far in 2025.
After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.
This brings the stock back to its September 2024 levels.
With shares at these…
Continue Reading
-
General13 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General22 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General20 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
Noosa News13 hours agoE-Scooter accident | Noosa Today